HONGPING REN, LAC
Acupuncture at 116 Ave, Bellevue, WA

License number

Washington AC00000450

Professional information

See more information about HONGPING REN at trustoria.com

Hongping Ren, Bellevue WA - LAC

Specialties:

Acupuncture

Address:

Authentic Chinese Acupuncture, PLLC
1370 116Th Ave NE SUITE 208, Bellevue 98004
(425) 646-6888 (Phone), (425) 646-6888 (Fax)

Procedures:

Acupuncture

Conditions:

Allergies, Anxiety Conditions, Asthma, Autoimmune Diseases, Car Accident Injuries, Depression, Digestive Disorders, Elbow Pain, Fibromyalgia, Hand Pain, Headache, Infertility, Insomnia, Menopause, Migraine, Neck Pain, Sciatica (Not Due to Disc Displacement), Shoulder Pain, Stress, Wrist Pain

Languages:

English, Chinese, Mandarin

Philosophy:

At Authentic Chinese Acupuncture, I committed to provide the best care and high quality services to my patients and their family. My philosophy of care is the integrity, compassion, accountability, respect, and excellence as my personal responsibility. I respect all my patients' values, needs, cultures, resources and strengths. My mission is to help my patients and their families achieve optimal health and happy lifestyle.

Education:

Medical School
Southern Illinois University
Graduated: 1990
Liaoning University Of Traditional Chinese Medicine
Graduated: 1983
Graduated: 1985

Hongping Ren, Bellevue WA

Specialties:

Acupuncturist

Address:

1370 116Th Ave Ne, Bellevue, WA 98004

Methods Of Using Il-31 To Treat Airway Hyper-Responsiveness And Asthma

US Patent:

2008026, Oct 23, 2008

Filed:

Jan 10, 2008

Appl. No.:

11/972596

Inventors:

Janine M. Bilsborough - Seattle WA, US
Eric M. Chadwick - Bellevue WA, US
Sherri L. Mudri - Seattle WA, US
Yue Yao - Kenmore WA, US
Hongping Ren - Kirkland WA, US
Jane A. Gross - Seattle WA, US

International Classification:

A61K 38/20, A61K 38/17, C12Q 1/68, C12Q 1/00, A61K 38/16

US Classification:

424 852, 514 12, 435 6, 435 4

Abstract:

Use of IL-31 agonists, including IL-31, are used to treat agonists are used to treat asthma, airway hyper-responsiveness or allergic rhinitis. The method comprise inhibiting, reducing, limiting or minimizing production of proimflammatory cytokines and include administration of the IL-31 agonsit during sensitization or challenge resulting in the asthma, airway hyper-responsiveness or allergic rhinitis state.